Technology | Lung Imaging | May 09, 2018

Body Vision Medical Receives FDA Clearance for LungVision Tool

Lung navigation catheter part of LungVision Platform for early-stage lung cancer diagnostics and treatment procedures

Body Vision Medical Receives FDA Clearance for LungVision Tool

May 9, 2018 — Body Vision Medical received clearance from the U.S. Food and Drug Administration (FDA) to market their LungVision Tool. The LungVision Tool is an affordable lung navigation catheter with what the company calls superb maneuverability. It is used in conjunction with standard bronchoscopes and the LungVision System to guide endotherapy accessories to small pulmonary nodules.

This approval clears the way for Body Vision Medical to accelerate commercialization efforts for its LungVision Platform for pulmonary specialists across the U.S., providing an affordable and effective real-time solution for early-stage lung cancer diagnostics and treatment procedures.

The LungVison Imaging and Navigation System was cleared by the FDA in May 2017 and has been successfully used in over 290 clinical procedures in 10 lung cancer centers across the U.S.

"Body Vision has pioneered a new generation platform for navigation bronchoscopy that applies an augmented reality approach to plan, visualize and accurately track radiolucent bronchial nodules in real time," said Krish Bhadra, M.D., from CHI Memorial Hospital, Chattanooga, Tenn. "The LungVision navigation tool has clear performance and cost benefits over current navigation tools that are bound to electromagnetic sensing."

The clinical experience from a multicentral study with the LungVision System will be presented at the American Thoracic Society Conference, May 18-23 in San Diego.

For more information: www.bodyvisionmedical.com

 

Related Content

Registration is now open for the Radiological Society of North America (RSNA) 107th Scientific Assembly and Annual Meeting, the world’s largest annual radiology forum, to be held at McCormick Place Chicago, Nov. 28 – Dec. 2, 2021

Getty Images

News | RSNA | July 21, 2021
July 21, 2021 — Registration is now open for the Radiological Society of North America (...
Nearly one quarter of deaths from lung cancer could be avoided in high-risk populations through the adoption of targeted screening with low-dose computed tomography (LDCT) scans, as based on the results of the NELSON study.

Getty Images

News | Computed Tomography (CT) | July 11, 2021
July 11, 2021 — The report ‘Lung Cancer Screening: The Cost of Inaction’ shows that lung cancer screening pres
More complex, longer interventional procedures such as structural heart interventions or this revascularization of a coronary chronic total occlusion (CTO) at Henry Ford Hospital in Detroit, requires angiography imaging systems that have improved image detail and lower radiation dose. However, purchase of new systems was put on hold by many hospitals in 2020 due to the sudden drop in elective procedures and diversion of resources due to the COVID-19. Photo by Dave Fornell.

More complex, longer interventional procedures such as structural heart interventions or this revascularization of a coronary chronic total occlusion (CTO) at Henry Ford Hospital in Detroit, requires angiography imaging systems that have improved image detail and lower radiation dose. However, purchase of new systems was put on hold by many hospitals in 2020 due to the sudden drop in elective procedures and diversion of resources due to the COVID-19. Photo by Dave Fornell.

Feature | Mobile C-Arms | July 07, 2021 | By Bhvita Jani
With the postponement of non-essential elective surgeries and medical procedures in 2020 to conserve medical resource
Now a new study from Boston University School of Medicine (BUSM) highlights the impact that structural racism and residential segregation has on NSCLC outcomes.

Getty Images

News | Lung Imaging | June 29, 2021
June 29, 2021 — Lung cancer remains the leading cause of
Patients with primary lung cancer detected using low-dose computed tomography screening are at reduced risk of developing brain metastases after diagnosis, according to a study published in the Journal of Thoracic Oncology.

Image courtesy of Canon

News | Computed Tomography (CT) | June 25, 2021
June 25, 2021 — Patients with primary lung cancer detect
COVID-19 progression over 4 days in a 28-year-old man. This posteroranterior chest X-ray \ shows bilateral multiple peripheral and lower lobe ground glass opacities (GGOs) shown by the arrows. Image courtesy of Margarita Revzin et al. 

COVID-19 progression over 4 days in a 28-year-old man. This posteroranterior chest X-ray \ shows bilateral multiple peripheral and lower lobe ground glass opacities (GGOs) shown by the arrows. Image courtesy of Margarita Revzin et al. 

News | Artificial Intelligence | June 24, 2021
June 24, 2021 — Artificial intelligence
An example of a COVID-19 pneumonia of a chest CT scan. The COVID appears as white ground glass opacities (GGOs) in the lungs. Normal lungs on CT should appear black.

An example of a COVID-19 pneumonia of a chest CT scan. The COVID appears as white ground glass opacities (GGOs) in the lungs. Normal lungs on CT should appear black.

News | Coronavirus (COVID-19) | June 23, 2021
June 23, 2021 — The Radiological Society of North America (...
Positron emission tomography (PET) using a 68Ga-labeled fibroblast activation protein inhibitor (FAPI) can noninvasively identify and monitor pulmonary fibrosis, according to research presented at the Society of Nuclear Medicine and Molecular Imaging 2021 Annual Meeting.

A) Axial CT images through the mouse lungs at 7 and 14 days after intratracheal administration of bleomycin or saline (as a control), demonstrating increased lung fibrosis in the bleomycin group (white arrows). (B) CT attenuation histograms in Hounsfield units (HU) after lung segmentation demonstrate increased attenuation in the lungs in the bleomycin group than the control group (p <0.05), consistent with increasing fibrosis (n=3). (C) Representative axial PET/CT fusion images at 20 and 60 min demonstrating increased FAPI uptake in the lungs of the bleomycin group (white arrows) with no significant uptake in the control group (yellow arrows). (D) Time-activity curve of lung uptake ROI analysis demonstrating higher FAPI uptake in the lungs of the bleomycin group than the control (p < 0.05), 14 days after bleomycin (n=3). (E) Ex vivo biodistribution data of lung tissue demonstrating higher radiotracer uptake in the lungs of the bleomycin group than the control (n=3). *p<0.05, **p<0.01. Image created by CA Ferreira et al., University of Wisconsin-Madison, Madison, WI.

News | PET-CT | June 14, 2021
June 14, 2021 — Positron emission tomography (PET) using
An abbreviated lung ultrasound protocol can efficiently determine presence of lung congestion in patients receiving hemodialysis and help expedite care. Chart courtesy of Reisinger et al, AJKD 2021

An abbreviated lung ultrasound protocol can efficiently determine presence of lung congestion in patients receiving hemodialysis and help expedite care. Chart courtesy of Reisinger et al, AJKD 2021

News | Lung Imaging | June 04, 2021
June 4, 2021 — ...